KOATE: payments to doctors
Payments that named KOATE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $532K
- Providers
- 1,340
- Transactions
- 1,999
- Average per transaction
- $266
The per-transaction average — $266 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,340 providers the average total is $397, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kedrion Biopharma, Inc. | $267,557 | 50.3% |
| Kedrion Biopharma Inc. | $264,209 | 49.7% |